COVID-19 MANAGEMENT IN CHILDREN: APPROACH IN PEDIATRIC CARDIOLOGY

Öz

In children, cardiac involvement can be observed during the course of COVID-19, which is mostly mild, and COVID-19 may develop in children who have previously been known to have congenital or acquired heart disease. The subject of this article is how these children should be evaluated cardiacly, and how the follow-up and treatment of children with heart disease will be managed during the pandemic. Considering the articles and guides published in the literature, some determinations were made and the suggestions developed were presented in this article.

Anahtar Kelimeler

• Approach
• Cardiology
• Children
• COVİR-19
• Management

ÇOCUKLARDA COVID-19 YÖNETİMİ: ÇOCUK KARDİYOLOJİDE YAKLAŞIM

Öz

Çocuklarda çoğu zaman hafif seyreden COVID-19 seyri sırasında kardiyak tutulum görülebileceği gibi, daha önce doğumsal yada edinsel kalp hastalığı olduğu bilinen çocuklarda da COVID-19 gelişebilir. Bu çocukların kardiyak açıdan nasıl değerlendirilmesi gerektiği, ayrıca kalp hastalığı bulunan çocukların takip ve tedavilerinin pandemi süresince nasıl yönetileceği bu makalenin konusudur. Literatürde yayınlanmış olan makale ve rehberler dikkate alınarak bazı saptamalar yapılmış ve geliştirilen öneriler bu yazıda sunulmuştur.

Anahtar Kelimeler

• COVID-19
• Çocuklar
• Kardiyoloji
• Yaklaşım
• Yönetim

Kaynakça

1. 1. Shen KL, Yang YH, Jiang RM, Wang TY, Zhao DC, Jiang Y, et al. Updated diagnosis, treatment and prevention of COVID-19 in children. World J Pediatr. DOI: 10.1007/s12519-020-00362-4 (2020).
2. 2. Zimmermann P, Curtis N. Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children. Pediatr Infect Dis J. 39: 355-368. DOI: 10.1097/INF.0000000000002660 (2020).
3. 3. Shi Y, Wang X, Liu G, Zhu Q, Wang J, Yu H, et al. A quickly, effectively screening process of novel corona virus disease 2019 (COVID-19) in children in Shanghai, China. Ann Transl Med. 8: 241. DOI: 10.21037/atm.2020.03.22 (2020).
4. 4. Chang TH, Wu JL, Chang LY. Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysis. J Formos Med Assoc. DOI: 10.1016/j.jfma.2020.04.007 (2020).
5. 5. Tezer H, Bedir Demirdağ T. Novel coronavirus disease (COVID-19) in children. Turk J Med Sci. 50 (SI-1): 592-603. DOI: 10.3906/sag-2004-174 (2020).
6. 6. She J, Liu L, Liu W. COVID-19 epidemic: Disease characteristics in children. J Med Virol. DOI: 10.1002/jmv.25807 (2020). 7. Sinha IP, Harwood R, Semple MG, Hawcutt DB, Thursfield R, Narayan O, et al. COVID-19 infection in children. Lancet Respir Med. DOI: 10.1016/S2213-2600(20)30152-1 (2020).
7. 8. Zheng F, Liao C, Fan QH, Chen HB, Zhao XG, Xie ZG, et al. Clinical Characteristics of Children with COVID-19 in Hubei, China. Curr Med Sci. DOI: 10.1007/s11596-020-2172-6 (2020).
8. 9. Hong H, Wang Y, Chung HT, Chen CJ. Clinical characteristics of novel COVID-19 in newborns, infants and children. Pediatr Neonatol. 61: 131-132. DOI: 10.1016/j.pedneo.2020.03.001 (2020).

9. 10. Yasri S, Wiwanitkit V. Clinical features in pediatric COVID-19. Pediatr Pulmonol. DOI: 10.1002/ppul.24737 (2020). 11. Li Y, Guo F, Cao Y, Li L, Guo Y. Insight into COVID-19 for pediatricians. Pediatr Pulmonol. 55: E1-E4. DOI: 10.1002/ppul.24734 (2020).
10. 12. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 Infection in Children. N Engl J Med. 382: 1663-1665. DOI: 10.1056/NEJMc2005073 (2020).
11. 13. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. DOI: 10.1542/peds.2020-0702 (2020).
12. 14. Cruz AT, Zeichner SL. COVID-19 in Children: Initial Characterization of the Pediatric Disease. Pediatrics. DOI: 10.1542/peds.2020-0834 (2020).
13. 15. Sun D, Li H, Lu XX, Xiao H, Ren J, Zhang FR, et al. Clinical features of severe pediatric patients with COVID-19 in Wuhan: a single center's observational study. World J Pediatr. DOI: 10.1007/s12519-020-00354-4 (2020).
14. 16. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 17: 259-260. DOI: 10.1038/s41569-020-0360-5 (2020).
15. 17. Cui Y, Tian M, Huang D, Wang X, Huang Y, Fan L, et al. A 55-Day-Old Female Infant infected with COVID-19: presenting with pneumonia, liver injury, and heart damage. J Infect Dis. DOI: 10.1093/infdis/jiaa113 (2020).
16. 18. Li W, Zhou Q, Tang Y, Ren L, Yu X, Li Q, et al. Protocol for the development of a rapid advice guideline for prevention, management and care of children with 2019 novel coronavirus infection. Ann Palliat Med. DOI: 10.21037/apm.2020.02.33 (2020).
17. 19. Shen K, Yang Y, Wang T, Zhao D, Jiang Y, Jin R, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children. World J Pediatr. DOI: 10.1007/s12519-020-00343-7 (2020).
18. 20. COVID-19 Guidance for Vulnerable Groups with Congenital Heart Disease. British Congenital Cardiac Association. March 18, 2020.
19. 21. Coronavirus Guidance for Adult & Pediatric Patients with Congenital Heart Disease. University of Michigan. March 27, 2020.
20. 22. COVID-19 (SARS-CoV2 Enfeksiyonu) Rehberi. T.C. Sağlık Bakanlığı Bilim Kurulu. Nisan 2020.
21. 23. COVID-19 Pandemi Sürecinde Çocuk Kalp Sağlığı Hizmetlerinin Yürütülmesi ve İnfekte Çocukların Kardiyak Yönden Değerlendirilmesi Rehberi. Türk Pediatrik Kardiyoloji ve Kalp Cerrahisi Derneği. Nisan 17, 2020.
22. 24. Kirkpatrick JN, Mitchell C, Taub C, Kort S, Hung J, Swaminathan M. ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak. JASE. DOI: 10.1016/j.echo.2020.04.001 (2020).
23. 25. Morray BH, Gordon BM, Crystal MA, et al. Resource Allocation and Decision Making for Pediatric and Congenital Cardiac Catheterization During the Novel Coronavirus SARS-CoV-2 (COVID-19) Pandemic. J Invasive Cardiol. PII: JIC20200409-2 (2020).
24. 26. Lee-Archer P, von Ungern-Sternberg BS. Paediatric Anaesthetic implications of COVID-19: A Review of Current Literature. Paediatr Anaesth. DOI: 10.1111/pan.13889 (2020).
25. 27. Zhao S, Ling K, Yan H, Zhong L, Peng X, Yao S, et al. Anesthetic Management of Patients with COVID-19 Infections during Emergency Procedures. J Cardiothorac Vasc Anesth. 34: 1125-1131. DOI: 10.1053/j.jvca.2020.02.039 (2020).
26. 28. Edelson DP, Sasson C, Chan PS, Atkins DL, Aziz K, Becker LB, et al. Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19. Circulation. DOI: 10.1161/CIRCULATIONAHA. 120.047463 (2020).
27. 29. Lakkireddy DR, Chung MK, Gopinathannair R, et al. Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic. Circulation. DOI: 10.1161/CIRCULATIONAHA.120.047063 (2020).
28. 30. Stephens EH, Dearani JA, Guleserian KJ, et al. COVID-19: Crisis Management in Congenital Heart Surgery. Ann Thorac Surg. DOI: 10.1016/j.athoracsur.2020.04.001 (2020).
29. 31. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19). JAMA. DOI: 10.1001/jama.2020.6019 (2020).
30. 32. Roden DM, Harrington RA, Poppas A, Russo AM. Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment. JACC. DOI: 10.1016/j.jacc.2020.04.016 (2020).
31. 33. Chiotos K, Hayes M, Kimberlin DW, Jones SB, James SH, Pinninti SG, et al. Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2. J Pediatric Infect Dis Soc. DOI: 10.1093/jpids/piaa045 (2020).